Allele Biotechnology's Exclusive Agent in Asia, Providing cGMP-grade iPSCs and Cell Therapy CDMO Services
Core Services:
cGMP/Clinical-grade Induced Pluripotent Stem Cells (iPSCs) and Differentiation (e.g. β Cells AiB)
- Clinically & Commercially Applicable to Phase 3 and Beyond
- iPSCs Qualified for Commercial Development from Phase 1
- 21CFR-Compliant Tissue Procurement and Ethical Tissue Procurement Onsite
- Qualified cGMP-Compliant Modular Facility Located in San Diego
- Integration Free mRNA-Based Protocols for iPSC Generation and Cell Differentiation
- Partnering for Custom Development of Cellular Therapeutics
- Private Clinical Grade iPSC Banking
